experimental obesity drug – The Milli Chronicle

Sunday, September 28, 2025

Latest:

India Highlights Resilience and Leadership Progress Across Key Developments
VHP Urges Peaceful Civic Engagement Amid Nationwide Waqf Law Protests in India
Kerala Raj Bhavan Launches ‘Rajhamsa’ Journal, Sparks Thoughtful Political Dialogue
India unveils reforms to elevate Indian Statistical Institute into a global center of excellence
Saudi Arabia Delivers Vital Food Aid and Life-Saving Medical Care Across Africa

Asia Health Latest Lifestyle News

NewsDesk Milli Chronicle September 25, 2025September 25, 2025 anti-obesity medication, clinical trials, diabetes and obesity treatment, diabetes medication, Eli Lilly, Eli Lilly India launch, Eli Lilly pharmaceutical update, experimental obesity drug, GLP-1 receptor agonist, GLP-1 treatment, health innovation, healthcare news India, innovative healthcare solutions, medical breakthrough India, new drug approval India, obesity management, pharmaceutical industry India, pharmaceutical launch India, weight management therapy, weight-loss pill India

Eli Lilly plans to bring experimental weight-loss pill in India

Mumbai, (Reuters) – Eli Lilly (LLY.N),plans to launch its experimental oral weight-loss drug orforglipron in India, a senior executive said on